Tate & Lyle's innovative ingredients can help food and beverage manufacturers tackle global diabetes epidemic

| Filed in:

New glycaemic response white paper from Tate & Lyle explores the role food and beverage manufacturers can play in developing products that help consumers manage blood glucose while following dietary guidelines

Glycaemic response white paper email

London, UK, 14 November 2019: Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, is proud to work with customers worldwide to improve the healthiness of the food supply. Diabetes affects over 425 million people globally (Source: International Diabetes Federation) and today’s World Diabetes Day provides food and beverage businesses with an opportunity to consider what more they can do to support global efforts to tackle Type II diabetes.

Given public health concerns surrounding the high incidence of diabetes and metabolic syndrome, managing blood glucose is very important. Tate & Lyle has published a white paper which explores the diabetes epidemic, dietary interventions and the role food and beverage manufacturers can play in developing products to help consumers manage blood glucose. It also looks at how Tate & Lyle’s innovative ingredients, such as fibres, rare sugars, and low and non-nutritive sweeteners, can help address glycaemic response in food and beverage products.

Dr. Kavita Karnik, VP Global Nutrition at Tate & Lyle, said:

"We believe people should be able to make healthy food and drink choices by having access to low calorie, low sugar and high fibre options. That's why we have a range of ingredients that food and beverage producers can use to make the products that, ultimately, could help prevent or manage incidences of Type II diabetes around the globe. We partner with our customers to help them not only achieve great tasting foods and beverages, but also to improve lives, and helping to prevent Type II diabetes with our ingredients is just one way we’re doing this."

Tate & Lyle’s range of fibres and sweeteners can help food and beverage manufacturers produce lower calorie, high fibre options for consumers that can help keep blood sugar at healthy levels, without compromising taste.

Tate & Lyle’s soluble fibre products are shown to significantly lower postprandial blood glucose and insulin levels. They include PROMITOR® Soluble Fibre and STA-LITE® Polydextrose soluble fibre. Our portfolio of non-nutritive sweeteners are low or zero calorie, but maintain the desired sweetness otherwise provided by sugar. They include DOLCIA PRIMA® Allulose, SPLENDA® Sucralose, Stevia Sweeteners and PUREFRUIT™ Monk Fruit Extract.

Learn more about how we partner with our customers to achieve food and beverage formulation goals, such as reducing sugar and calories.

# # #

Note to Editors

Media contact:

Miriam Wilkens, VP Global Communications, Tate & Lyle PLC, mediarelations@tateandlyle.com

Learn more from our white paper on Glycaemic Response

Click here for our press image gallery

About Tate & Lyle: 
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on LinkedinX (Twitter)Facebook or YouTube

Nutrition Centre logo 2023

Nutrition plays a key role in consumers’ lives

We address the health and nutritional needs of your consumers using our science-based innovative ingredient solutions. Discover how in our Nutrition Centre...

Off
Blue